Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
sumatriptan
|
| gptkbp:approvalYear |
1992
|
| gptkbp:ATCCode |
N02CC01
|
| gptkbp:contraindication |
ischemic heart disease
uncontrolled hypertension |
| gptkbp:drugClass |
triptan
|
| https://www.w3.org/2000/01/rdf-schema#label |
Glaxo (sumatriptan)
|
| gptkbp:indication |
migraine
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Glaxo
|
| gptkbp:mechanismOfAction |
serotonin 5-HT1B/1D receptor agonist
|
| gptkbp:routeOfAdministration |
oral
subcutaneous injection nasal |
| gptkbp:sideEffect |
dizziness
tingling drowsiness flushing |
| gptkbp:status |
FDA approved
|
| gptkbp:bfsParent |
gptkb:triptans
|
| gptkbp:bfsLayer |
7
|